| Segment | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Neuroscience | — | — | — | $73.00M | $83.00M | $77.00M | $79.00M | $80.00M |
| Cardiovascular | $53.00M | $55.00M | $56.00M | $56.00M | $64.00M | $64.00M | $56.00M | $66.00M |
| Medical Surgical | — | — | — | $51.00M | $56.00M | $54.00M | $53.00M | $62.00M |
| Diabetes Group | $20.00M | $24.00M | $27.00M | $30.00M | $33.00M | $31.00M | $32.00M | $32.00M |
| Other operating segment | — | — | — | $0.00 | — | — | — | $0.00 |
| Total | $50.75M | $49.00M | $51.00M | $51.00M | $56.00M | $54.00M | $53.00M | $62.00M |